Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce R Schackman

Showing results (71-80 of 221) with videos related to

Pageof 23
Sort By:
Substance Abuse|March 21, 2018
Implementation of a nationwide health economic consultation service to assist substance use researchers: Lessons learnedSean M Murphy, Jared A Leff, Benjamin P Linas, et al.
AIDS (London, England)|September 12, 2008
The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIVBruce R Schackman, Callie A Scott, Rochelle P Walensky, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 10, 2021
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature ReviewErica N Onuoha, Jared A Leff, Bruce R Schackman, et al.
Journal of General Internal Medicine|January 20, 2021
A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative StudyShashi N Kapadia, Judith L Griffin, Justine Waldman, et al.
AIDS Care|December 22, 2009
Feasibility of using audio computer-assisted self-interview (ACASI) screening in routine HIV careBruce R Schackman, Zubin Dastur, David S Rubin, et al.
Antiviral Therapy|February 22, 2007
Design issues in initial HIV-treatment trials: focus on ACTG A5095Heather J Ribaudo, Daniel R Kuritzkes, Bruce R Schackman, et al.
Alcoholism, Clinical and Experimental Research|September 18, 2020
Evaluation of Alcohol Taxes as a Public Health Opportunity to Reduce Liver Transplant Listings for Alcohol-Related Liver DiseaseNicole T Shen, Jeremy Bray, Nabeel A Wahid, et al.
Harm Reduction Journal|February 3, 2023
The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative studyMercy Ude, Czarina N Behrends, Shea Kelly, et al.
Archives of Internal Medicine|November 20, 2002
Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adultsBruce R Schackman, Kenneth A Freedberg, Milton C Weinstein, et al.
Open Forum Infectious Diseases|April 25, 2025
Providers' Perspectives on Implementation of Low-threshold HCV Treatment in New York State: A Qualitative StudyAne-Kristine Finbråten, Cristina L Chin, Meenakshi Seetharaman, et al.
Pageof 23

Showing results (71-80 of 221) with videos related to

Sort By:
Pageof 23
Substance Abuse|March 21, 2018
Implementation of a nationwide health economic consultation service to assist substance use researchers: Lessons learnedSean M Murphy, Jared A Leff, Benjamin P Linas, et al.
AIDS (London, England)|September 12, 2008
The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIVBruce R Schackman, Callie A Scott, Rochelle P Walensky, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 10, 2021
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature ReviewErica N Onuoha, Jared A Leff, Bruce R Schackman, et al.
Journal of General Internal Medicine|January 20, 2021
A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative StudyShashi N Kapadia, Judith L Griffin, Justine Waldman, et al.
AIDS Care|December 22, 2009
Feasibility of using audio computer-assisted self-interview (ACASI) screening in routine HIV careBruce R Schackman, Zubin Dastur, David S Rubin, et al.
Antiviral Therapy|February 22, 2007
Design issues in initial HIV-treatment trials: focus on ACTG A5095Heather J Ribaudo, Daniel R Kuritzkes, Bruce R Schackman, et al.
Alcoholism, Clinical and Experimental Research|September 18, 2020
Evaluation of Alcohol Taxes as a Public Health Opportunity to Reduce Liver Transplant Listings for Alcohol-Related Liver DiseaseNicole T Shen, Jeremy Bray, Nabeel A Wahid, et al.
Harm Reduction Journal|February 3, 2023
The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative studyMercy Ude, Czarina N Behrends, Shea Kelly, et al.
Archives of Internal Medicine|November 20, 2002
Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adultsBruce R Schackman, Kenneth A Freedberg, Milton C Weinstein, et al.
Open Forum Infectious Diseases|April 25, 2025
Providers' Perspectives on Implementation of Low-threshold HCV Treatment in New York State: A Qualitative StudyAne-Kristine Finbråten, Cristina L Chin, Meenakshi Seetharaman, et al.
Pageof 23